GLG News by Economic Experts on Managed Care

This article is important because it outlines the rationale and benefits of the new collagen based filler from Ortho-Neutrogena/ Johnson and Johnson. This filler appears to last at least 6 months, and does not require pre testing as other collagen based fillers have needed in the past. The fact that...

This article is important in that, for the most part , it describes a basic therapeutic regimen for adolescent acne patients. The only error is describing the inflamed lesions as "infections." Acne is predominantly an inflammatory condition, not an infectious one, though a bacteria is involved...

There will be an increased use of costly diaylsis, especially among those people 70 years or older.  One would think that there would be a greater awareness of a disease consting $31 billion dollars a year.  However, this does not seem to be the case.

This article is important in that this acquisition is the first new product for Allergan's dermatology division in several years. This is also the first novel molecule in 5-7 years that has been released. The issues of having to get blood tests with this topical agent have been solved. The obvious paring...

As a clinician leader for some time, it is overtly obvious that comprehensive genetic testing will be fraught with misinterpretation and will lead to consumer confusion and potentially wrong life behavior. Genetic testing has been available for 2-3 decades on a very limited basis and for specific fetal...

Although administrative and nursing/allied medical staff can and will respond to the Quality challenges, physicians (forgive my stereotyping) must be approached more comprehensively to elicit medical behavioral change based on evidenced based medicine or process improvement.  They will slow the...

After abandoning a 2007 IPO, Talecris majority owner Cerberus Capital is now reported to be pursuing negotiations to sell the $1.2 billion plasma products firm. Talecris' valuation will necessarily involve projections of worldwide market demand for intravenous immunoglobulin (IVIg), the industry's most...

If a report in the Financial Times is credible, the already consolidating plasma products industry could render down to even fewer players in the near future with the sale of Talecris to a major competitor. The value of the company will be strongly influenced by the direction in demand for its industry's...

The sale of Datascope's (NASDAQ: DSCP) patient monitoring business earlier this year to Mindray Medical (NYSE: MR) has resulted in several acquisition offers from unnamed companies.  On Wednesday, Datascope's stock increased 11% in response to this news.   

While no more would argue that control of systolic hypertension is crucial to preventing the consequences of hypertension such as congestive heart failure, MI's, left ventricular hyperthrophy, stroke and kidney failure there are other factors that are associated with these disease states. One of these...